Notice for oveporexton (Takeda Pharmaceuticals Australia Pty Ltd)
Active ingredients
oveporexton
Date of review outcome
Lapse date
Type
Priority review
Indication
Treatment of narcolepsy type 1
Therapeutic area
Sleep medicine